Gaudium IVF and Women Health files IPO papers to fund expansion, working capital requirements

Gaudium IVF and Women Health IPO

New Delhi-based in vitro fertilization treatment provider Gaudium IVF and Women Health has filed draft papers with SEBI to raise funds via initial public offering for funding expansion plan and working capital requirements.

Incorporated in 2015, Dr Manika Khanna-promoted Gaudium IVF has a PAN-India presence, operating business through more than 30 locations, comprising of 7 hubs (centers) and 28 spokes.

The Gaudium IVF IPO will be a combination of fresh issuance of 1.83 crore equity shares, and an offer-for-sale of 25.31 lakh shares by the promoter.

The fresh issue proceeds will be spent for establishment of new IVF centers, working capital requirements, and launching of FMCG products.

Click Here To Read All IPO News

Sarthi Capital Advisors is appointed as the sole book running lead manager for the issue.

There are no comparable peers among listed entities.

On the financials front, Gaudium IVF has recorded profit at Rs 16.6 crore for the fiscal 2024, growing 22.7 percent over the previous financial year and revenue increased by 20.9 percent to Rs 53.5 crore during the same period. Profit in the six months period ended September 2024 stood at Rs 8.1 crore on revenue of Rs 31.7 crore.

Meanwhile, in the November last year, Moneycontrol reported that EQT AB-backed Indira IVF is planning to raise about $400 million via initial public offering. Stockholm-based investment firm EQT AB is working with arrangers to help prepare for an IPO in Mumbai as soon as this year (2025), and a share sale could value the IVF clinic operator at about $2.5 billion, according to reports.